Steroidogenesis-inducing protein, isolated from human ovarian follicular fluid, is a potent mitogen for cell lines derived from ovarian surface epithelial carcinomas

Gynecologic Oncology

Volumn 66, Issue 3, 1997, Pages 501-508

  Khan, S A ^a,b   Matysiak Zablocki, E ^d   Ball, R ^a   Krtolica, A ^c   Hawkins, G ^a   Ghahremani, M ^d   Ludlow, J W ^c   Dorrington, J ^d  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BUCLADESINE; INTERLEUKIN 1; MITOGENIC AGENT; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN C; STEROIDOGENESIS INDUCING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MITOSIS RATE; OVARY CARCINOMA; OVARY FOLLICLE FLUID; OVULATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN INDUCTION; PROTEIN ISOLATION; STEROIDOGENESIS;

EID: 0031239908     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4782     Document Type: Article

References (45)

1. 1. Wingo PA, Tong T, Bolden S: Cancer statistics, 1995. Ca J Clin 45:8-30, 1995
2. 2. Omura GA, Brady MF, Homesley HD, et al.: Long term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. J Clin Oncol 9:1138-1150, 1991
3. 3. Silverberg E: Statistical and Epidemiological Information in Gynecologic Cancer. New York, American Cancer Society, 1986.
4. 4. Whittemore AS, Harris R, Itnyre J: Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women: collaborative ovarian cancer group. Am J Epidemiol 136:1184-1203, 1992
5. 5. Heintz APM, Hacker N, LaGasse L: Epidemiology and etiology of ovarian cancer: a review. Obstet Gynecol 66:127-135, 1985
6. 6. NIH Consensus Development Panel: Ovarian cancer screening, treatment and follow-up. JAMA 273:491-497, 1995
7. 7. Whitman GF, Nolan TE, Gallup DG: Normal Ovarian Development and Function, in Cancer of the Ovary Markman M, Hoskins WJ (eds): New York, Raven Press, 1993, pp 1-20
8. 8. Harrison RJ: The Structure of the Ovary, in (Zuckerman S ed): The Ovary New York, Academic Press, 1962, pp 143
9. 9. Fathalla MF: Factors in the causation and incidence of ovarian cancer. Obstet Gynenol Surv 27:751-768, 1972
10. 10. Varmus HE: The molecular genetics of cellular oncogenes. Annu Rev Genet 18:553-561, 1984
11. 11. Godwin AK, Testa JR, Handel LM, et al.: Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulations in the etiology of ovarian cancer. LNCL 84:592-601, 1992
12. 12. McGowan L, Parent L, Lednar W, et al.: The woman at risk of developing ovarian cancer. Gynecol Oncol 7:325-344, 1979
13. 13. Mills GB, Hashimoto S, Hurteau JA, et al.: Role of growth factors, their receptors and their signalling pathways in the diagnosis, prognosis, follow up and therapy of ovarian cancer. Diag Oncol 2:39-54, 1992
14. 14. Kruk PA, Maines-Bandiera SL, Auersperg N: A simplified method to culture human ovarian epithelial cells. Lab Invest 63:132-136, 1990
15. 15. Gougeon A: Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod 1:81-87, 1986
16. 16. Skinner MK, Lobb D, Dorrington JH: Ovarian thecal/interstitial cells produce an epidermal growth factor-like substance. Endocrinology 121:1892, 1987
17. 17. Skinner MK, Keski-oja J, Osteen KG, Moses HL: Ovarian thecal cells produce transforming growth factor-β which can regulate granulosa cell growth. Endocrinology 121:786, 1987
18. 18. Roby KF, Weed J, Lyles R, Terranova PF: Immunological evidence for a human ovarian tumor necrosis factor-α. J Clin Endocrinol Metab 71:1096-1102, 1990
19. 19. Schomberg DW: Growth factors and Reproduction, in Hodgen GD, Rosenwaks Z, Spieler JM (eds): Nonsteroidal Gonadal Factors. Norfolk, Jones Institute Press, 1988, pp 330-338
20. 20. Adashi EY, Resnick CE, D'Ercole AJ, Svoboda ME, Van Wyk JJ: Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocrine Rev 6:400-420, 1985
21. 21. Khan SA, Schmidt K, Hallin P, Di Pauli R, De Geyter C, Nieschlag E: Human testis cytosol and ovarian follicular fluid contain high amounts of interleukin-1-like factor(s). MoI Cell Endocrinol 58:221-230, 1988
22. 22. Buick RN, Pullano R, Trent JM: Comparitive properties of five human ovarian adenocarcinoma cell lines. Cancer Res 45:3668-3676, 1985
23. 23. Rofstad E, Sutherland RM: Radiation sensitivity of human ovarian carcinoma cell lines in vitro: effects of growth factors and hormones, basement membrane, and intercellular contact. Int J Radiat Oncol Biol Phys 15:921-929, 1988
24. 24. Khan SA, Hallin P, Bartlett J, De Geyter C, Nieschlag E: Characterization of a factor from human ovarian follicular fluid which stimulates Leydig cell testosterone production. Acta Endocrinol 118:283-293, 1988
25. 25. Khan SA, Keck C, Gudermann T, Nieschlag E: Isolation of a protein from human ovarian follicular fluid which stimulates steroid production of testicular, ovarian and adrenal cells. Endocrinology 126:3043-3052, 1990
26. 26. Khan SA, Teerds K, Dorrington JH: Steroidogenesis-inducing protein promotes DNA synthesis in Leydig cells from immature rats. Endocrinology 130:599-606, 1992
27. 27. Khan S, Shum L, Teerds K, Dorrington JH: Steroidogenesis inducing protein interacts with TGFβ to stimulate DNA synthesis in rat granulosa cells. Mol Cell Endocrinol 89:97-103, 1992
28. 28. Krtolica A, Ludlow JW: Hypoxia arrests ovarian carcinoma cell cycle progression, but invasion is unaffected. Cancer Res 56:1168-1173, 1996
29. 29. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
30. 30. Berchuck A, Bast RC Jr: Growth Factors, Oncogenes, and Tumor Suppressor Genes, in Markman M, Hoskins WJ (eds): Cancer of the Ovary, New York, Raven Press, 1993, pp 61-78
31. 31. Daughaday WH, Rotwein P: Insulin-like growth factors I and II: peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocrine Rev 10:68-91, 1989
32. 32. Czech MP: Signal transmission by the insulin-like growth factors. Cell 59:235-238, 1989
33. 33. Lyons RM, Moses HL: Transforming growth factors and the regulation of cell proliferation. Eur J Biochem 187:467-473, 1990
34. 34. Hurteau J, Rodriguez GC, Whitaker RS, Shah S, Mills G, Bast RC Jr: Transforming growth factor-β inhibits proliferation of human ovarian cancer cells obtained from ascites. Cancer 74:93-99, 1994
35. 35. Spaulding SW: The ways in which hormones change cyclic adenosine 3′,5′-monophosphate dependent protein kinase subunits, the how such changes affect cell behavior. Endocrine Rev 14:632-650, 1993
36. 36. Rodriguez GC, Berchuck A, Whitaker RS, Schlossman D, Clarke-Pearson D, Bast RC Jr: Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer. II. Relationship between receptor expression and response to epidermal growth factor. Am J Obstet Gynecol 164:745-750, 1991
37. 37. Khan SA, Dorrington JH, Moran MF: Steroidogenesis-inducing protein stimulates protein tyrosine kinase activity in rat Leydig cells. Endocrinology 132:109-114, 1993
38. 38. Khan SA, Khan SJ, Dorrington JH: Interleukin-1 stimulates deoxyribonucleic acid synthesis in rat Leydig cells in vitro. Endocrinology 131:1853-1857, 1992
39. 39. Wu S, Boyer CM, Whitaker RS, Berchuck A, Wiener JR, Weinberg JB, Bast RC Jr: Tumor necrosis factor α as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor α expression. Cancer Res 53:1939-1944, 1993
40. 40. Malik S, Balkwill F: Epithelial ovarian cancer: a cytokine prepelled disease? Br J Cancer 64:617-620, 1991
41. cdc2 synthesis by transforming growth factor-β1 in cycling epithelial cells. Cell Growth Differ 5:109-116, 1994
42. 42. Birnbaumer L: G proteins in signal transduction. Annu Rev Pharmacol Toxicol 30:675-705, 1990
43. 43. Richards JS: Hormonal control of ovarian follicular development. A 1978 perspective. Rec Prog Horm Res 35:343, 1979
44. 44. DiSaia PJ, Creasman WT: Epithelial ovarian cancer, in Manning S (ed): Clinical Gynecologic Oncology St. Louis, Mosby Year Book, 1993, pp 333-425
45. 45. Bendell JJ, Dorrington J: Estradiol-17β stimulates DNA synthesis in rat granulosa cells: actions mediated by transforming growth factor-β. Endocrinology 128:2663-2665, 1991